-

nihao guest [ sign in / register ]
2024-11-26 20:36:29
Article

Kissling E, et al. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019 Feb;24(8)..  Abstract  
submitted by kickingbird at Feb, 28, 2019 from Euro Surveill. 2019 Feb;24(8). (via https://www.eurosurveillance.org/content/10.2807/1560-7917.E)
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates ...

Corbett KS, et al. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages. MBio. 2019 Feb 26;10(1)..  Abstract  
submitted by kickingbird at Feb, 28, 2019 from MBio. 2019 Feb 26;10(1). (via https://mbio.asm.org/content/10/1/e02810-18)
Influenza vaccines targeting the highly conserved stem of the hemagglutinin (HA) surface glycoprotein have the potential to protect against pandemic and drifted seasonal influenza viruses not covered by ...

Kramer SC, Shaman J. Development and validation of influenza forecasting for 64 temperate and tropical countries. PLoS Comput Biol. 2019 Feb 27;15(2):e1006742..  Abstract  
submitted by kickingbird at Feb, 28, 2019 from PLoS Comput Biol. 2019 Feb 27;15(2):e1006742. (via https://journals.plos.org/ploscompbiol/article?id=10.1371/jo)
Accurate forecasts of influenza incidence can be used to inform medical and public health decision-making and response efforts. However, forecasting systems are uncommon in most countries, with a few notable ...

Farsakoglu Y, et al. Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent Manner. Cell Rep. 2019 Feb 26;26(9):2307-2315.e5.  Abstract  
submitted by kickingbird at Feb, 28, 2019 from Cell Rep. 2019 Feb 26;26(9):2307-2315.e5 (via https://www.cell.com/cell-reports/fulltext/S2211-1247(19)301)
The role of natural killer (NK) cells in the immune response against vaccines is not fully understood. Here, we examine the function of infiltrated NK cells in the initiation of the inflammatory response ...

Klifa R, et al. Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices. BMC Nephrol. 2019 Feb 25;20(1):65..  Abstract  
submitted by kickingbird at Feb, 27, 2019 from BMC Nephrol. 2019 Feb 25;20(1):65. (via https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882)
BACKGROUND: Annual influenza vaccination is recommended for all children with idiopathic nephrotic syndrome (INS) in France. Consequently, the Social Security automatically sends prescriptions to all patients ...

Rich HE, et al. Interferon Lambda Inhibits Bacterial Uptake During Influenza Super-Infection. Infect Immun. 2019 Feb 25.  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Infect Immun. 2019 Feb 25 (via https://iai.asm.org/content/early/2019/02/22/IAI.00114-19)
Influenza kills 30-40,000 people each year in the United States, and causes ten times as many hospitalizations. A common complication of influenza is bacterial super-infection, which exacerbates morbidity ...

Jorquera PA, et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011~2018. Sci Rep. 2019 Feb 25;9(1):2676..  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Sci Rep. 2019 Feb 25;9(1):2676. (via https://www.nature.com/articles/s41598-019-39276-1)
Influenza A(H3N2) viruses evade human immunity primarily by acquiring antigenic changes in the haemagglutinin (HA). HA receptor-binding features of contemporary A(H3N2) viruses hinder traditional antigenic ...

Holzer B, Martini V, Edmans M, Tchilian E. T and B Cell Immune Responses to Influenza Viruses in Pigs. Front Immunol. 2019 Feb 5;10:98..  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Front Immunol. 2019 Feb 5;10:98. (via https://www.frontiersin.org/articles/10.3389/fimmu.2019.0009)
Influenza viruses are an ongoing threat to humans and are endemic in pigs, causing considerable economic losses to farmers. Pigs are also a source of new viruses potentially capable of initiating human ...

Worobey M, Cox J, Gill D. The origins of the great pandemic. Evol Med Public Health. 2019 Jan 21;2019(1):18-25.  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Evol Med Public Health. 2019 Jan 21;2019(1):18-25 (via https://academic.oup.com/emph/article/2019/1/18/5298310)
The timing and location of the first cases of the 1918 influenza pandemic are still controversial, a century after the pandemic became widely recognized. Here, we critically review competing hypotheses ...

Abusrewil S, et al. Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network. Influenza Other Respir Viruses. 2019 Feb 22..  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Influenza Other Respir Viruses. 2019 Feb 22. (via https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12628)
The Middle-East and Africa Influenza Surveillance Network (MENA-ISN), established in 2014, includes 15 countries at present. Country representatives presented their influenza surveillance programmes, vaccine ...

McGee CE, et al. Influenza-Mediated Lung Infection Models. Methods Mol Biol. 2019;1960:191-205..  Abstract  
submitted by kickingbird at Feb, 27, 2019 from Methods Mol Biol. 2019;1960:191-205. (via https://www.ncbi.nlm.nih.gov/pubmed/30798533)
Laboratory rodent influenza infection models have been and continue to be a critical tool for understanding virus-host interactions during infection. The incidence of seasonal influenza infections coupled ...

Wang Z, et al. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine. Vaccine. 2019 Feb 20..  Abstract  
submitted by kickingbird at Feb, 25, 2019 from Vaccine. 2019 Feb 20. (via https://www.sciencedirect.com/science/article/pii/S0264410X1)
BACKGROUND: Antigenic drift of H9N2 low pathogenic avian influenza viruses (AIV) may result in vaccination failure in the poultry industry and thus a cross-protective vaccine against H9N2 AIV is highly ...

Su K, et al. Influenza A(H7N9) virus emerged and resulted in human infections in Chongqing, southwestern China since 2017. Int J Infect Dis. 2019 Feb 21.  Abstract  
submitted by kickingbird at Feb, 25, 2019 from Int J Infect Dis. 2019 Feb 21 (via https://www.ijidonline.com/article/S1201-9712(19)30075-X/pdf)
OBJECTIVES: Influenza A(H7N9) virus emerged and resulted in human infections in Chongqing, southwestern China since 2017. This study aimed to describe the epidemiological characteristics of the first epidemic ...

Morita A, et al. Nationwide survey of influenza-associated acute encephalopathy in Japanese adults. J Neurol Sci. 2019 Feb 10;399:101-107.  Abstract  
submitted by kickingbird at Feb, 25, 2019 from J Neurol Sci. 2019 Feb 10;399:101-107 (via https://www.jns-journal.com/article/S0022-510X(19)30065-6/fu)
BACKGROUND: Knowledge of adult patients with influenza-associated acute encephalopathy (IAE) is limited. We conducted a detailed survey to investigate the prevalence, clinical features, associated outcomes, ...

Rao GK, et al. In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection. Toxicol Sci. 2019 Feb 22..  Abstract  
submitted by kickingbird at Feb, 24, 2019 from Toxicol Sci. 2019 Feb 22. (via https://academic.oup.com/toxsci/advance-article-abstract/doi)
A theoretical safety concern proposed in the influenza literature is that therapeutic anti-viral antibodies could have the potential for antibody-dependent enhancement (ADE) of infection and disease. ADE ...

Gooch KE, et al. Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza. Sci Rep. 2019 Feb 22;9(1):2617.  Abstract  
submitted by kickingbird at Feb, 24, 2019 from Sci Rep. 2019 Feb 22;9(1):2617 (via https://www.nature.com/articles/s41598-019-38885-0)
An effective universal vaccine for influenza will likely need to induce virus-specific T-cells, which are the major mediator of heterosubtypic cross-protection between different subtypes of influenza A ...

Henry C, et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host Microbe. 2019 Jan 24.  Abstract  
submitted by kickingbird at Feb, 24, 2019 from Cell Host Microbe. 2019 Jan 24 (via https://www.sciencedirect.com/science/article/pii/S193131281)
Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically ...

Lee J, et al. Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. Cell Host Microbe. 2019 Feb 6..  Abstract  
submitted by kickingbird at Feb, 24, 2019 from Cell Host Microbe. 2019 Feb 6. (via https://www.sciencedirect.com/science/article/pii/S193131281)
Humans are repeatedly exposed to influenza virus via infections and vaccinations. Understanding how multiple exposures and pre-existing immunity impact antibody responses is essential for vaccine development. ...

Wang SH, et al. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge. Vaccine. 2019 Feb 19..  Abstract  
submitted by kickingbird at Feb, 24, 2019 from Vaccine. 2019 Feb 19. (via https://www.sciencedirect.com/science/article/pii/S0264410X1)
BACKGROUND: Highly pathogenic H5N1 influenza viruses remain a pandemic risk to the world population. Although vaccines are the best solution to prevent this threat, a more effective vaccine for H5 strains ...

Awadalla M, et al. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. J Immunother Cancer. 2019 Feb 22;7(1):53.  Abstract  
submitted by kickingbird at Feb, 24, 2019 from J Immunother Cancer. 2019 Feb 22;7(1):53 (via https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0)
BACKGROUND: Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events ...

8181 items, 20/Page, Page[199/410][|<<] [|<] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [>|] [>>|]

Related Pages:

Browse by Category
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!


  

Site map  |   Contact us  |  Term of use  |  FAQs |  粤ICP备10094839号-1
Copyright ©www.flu.org.cn. 2004-2024. All Rights Reserved. Powered by FIC 4.0.1
  Email:webmaster@flu.org.cn